Q fever was described for the first time in 1937 in Australia (7) . Since then, the worldwide distribution of the disease has been recognized. Coxiella burnetii is an obligate intracellular rickettsial organism, which causes Q fever in animals and humans. This bacterium was named after F. M. Burnet, who discovered the microorganism in the spleens of experimentally infected mice (7) , and after H. R. Cox , who succeeded in culturing it in embryonated eggs (5) .
Human infections result from contact with infected sheep, goats, or cattle or from infected placentas. Although infections in animals are usually inapparent, apart from causing more frequent abortions, the most common clinical presentation in humans is an influenzalike disease, often accompanied by pneumonia (2) . However, chronic disease, particularly endocarditis, may appear years after the primary episode (13, 22) .
The diagnosis of both primary and chronic Q fever by serology is desirable, since culturing the organism is hazardous and requires specially equipped laboratories.
Unique to C. burnetii is its antigenic-phase variation. The virulent phase I is isolated during natural or laboratory infections of humans or animals, whereas the avirulent phase II develops during serial passage in immunologically incompetent hosts, such as fertilized eggs or cell cultures. This phase transition seems to relate to some of the biological characteristics of the smooth-rough lipopolysaccharide variation (1). Serologically, anti-phase I antibodies are present at high titers only during the chronic form of the illness, whereas anti-phase II antibodies are largely predominant in primary acute Q fever (18) .
In 1948 Gsell (12) (9) .
Since 1983, a few papers have dealt with immunoenzymatic tests for the diagnosis of Q fever (8, 11, 21 The serum samples were also tested by the standard CF micrornethod (17) with an antigen phase II, strain Nine Mile (Virion International), as described previously (19) . Screen (Fig. 1) , as well as the ELISA and CF (Fig. 2) , were compared for 140 serum samples from Leytron and Sion together ( Table 1 ). The ELISA revealed 43 positive samples, of which 9 were negative by IFA (Fig. 1) . Two samples found positive by IFA were negative by ELISA. Of the same 43 ELISA-positive samples, 19 were negative by CF, and 3 CF-positive samples were negative by ELISA (Fig. 2) .
Of the 213 patients having had Q fever 1 year previously ( Fig. 3 and 4 (Fig. 4) .
Specificity. The paired serum samples from the three patients suffering from Q fever, which were included as a control, showed a seroconversion, the OD values varying from 0.07 to 0.60 and from 0.16 to 1.06 for the first two cases and showing a high increase for the third (0.41 to 0.92).
On the other hand, no significant OD variations were observed between the paired serum samples from patients with acute pneumonia of other origin. However, the OD value of two paired serum samples varied from 0.33 to 0.38 (negative to positive) and the other varied from 0.36 to 0.28 (positive to negative); however, all four samples showed OD values close to the cutoff value of 0.35 + 0.06 (standard deviation). Similarly, we did not observe any significant variation of the titers with the IFA and CF tests, except for the three acute Q fever cases.
DISCUSSION
Our findings suggest that the sensitivity of the ELISA is superior to those of the IFA and CF tests. Indeed, the ELISA detected more positive serum samples from patients who had had Q fever 1 year previously (10) 
